AnaptysBio CFO Chris Murphy scheduled to present at H.C. Wainwright conference
AnaptysBio said Chris Murphy, its CFO, is scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference.
SAN DIEGO, Sept.
01, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc.
NASDAQ:ANAB, a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that Chris Murphy, chief financial officer, is scheduled to present at the H.C.
Wainwright 28th An…